Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
Source abstract
Abstract
Hair loss represents a condition that adversely affects the social life of patients. The most common cause is androgenetic alopecia (AGA), which is a genetically determined progressive hair-loss condition involving 5α-reductase. In this study, a novel anti-baldness agent based on Interconnected PolymerS TeChnology (IPSTiC), which is an effective strategy for the delivery of bioactive molecules, was developed. This product (IPSTiC patch hair) is based on a polymeric blend consisting of high molecular weight hyaluronic acid and soybean proteins and is able to improve efficacy and stability of bioactive ingredients such as Origanum vulgare leaf extract, Camellia Sinensis leaf extract, and Capsicum Annuum fruit extract. The efficacy of the developed anti-baldness agent was investigated by performing several tests including NO radical and 5α-reductase inhibition assays, stability studies under different conditions, and in vitro diffusion studies using Franz cells. The biocompatibility of IPSTiC patch hair was also evaluated by in vitro analysis of the pro-sensitising potential and EPISKIN model. The obtained results confirmed both the efficacy and safety of IPSTiC patch hair supporting the potential use of this product in the topical treatment of AGA.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hair Growth and Disorders · Skin Protection and Aging · melanin and skin pigmentation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy
Macrofarm s.r.l., c/o Department of Pharmacy, Health and Nutrition Sciences, University of Calabria, 87036 Rende (CS), Italy
References (54)
Show source-provided references
1. 5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment10.1016/j.jep.2011.12.010 ↗
2. Multi-therapies in androgenetic alopecia: Review and clinical experiences10.1111/dth.12390 ↗
3. Effect of IGF-I on hair growth is related to the anti-apoptotic effect of IGF-I and up-regulation of PDGF-A and PDGF-B10.5021/ad.2012.24.1.26 ↗
4. Male pattern baldness: Current treatments, future prospects10.1016/j.drudis.2008.05.010 ↗
5. Androgenetic alopecia: Pathogenesis and potential for therapy10.1017/S1462399402005112 ↗
6. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia10.1016/0190-9622(93)70106-4 ↗
7. Lipid peroxides induce early onset of catagen phase in murine hair cycles
8. Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
9. Pattern hair loss in men: Diagnosis and medical treatment10.1016/j.det.2012.08.003 ↗
10. Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle10.1016/j.jdermsci.2004.01.002 ↗
11. Finasteride in the treatment of alopecia10.1517/14656566.5.4.933 ↗
12. A case of acute myocardial infarction associated with topical use of minoxidil (RiUP®) for treatment of baldness10.1536/jhj.41.519 ↗
13. Minoxidil-Associated Anorexia in an Infant with Refractory Hypertension10.1002/phar.1495 ↗
14. Guidelines on the use of finasteride in androgenetic alopecia10.4103/0378-6323.177432 ↗
15. Chaiyana, W., Punyoyai, C., Somwongin, S., Leelapornpisid, P., Ingkaninan, K., Waranuch, N., Srivilai, J., Thitipramote, N., Wisuitiprot, W., and Schuster, R. (2017). Inhibition of 5α-Reductase, IL-6 Secretion, and Oxidation Process of Equisetum debile Roxb. ex Vaucher Extract as Functional Food and Nutraceuticals Ingredients. Nutrients, 9.10.3390/nu9101105 ↗
16. Concise Review: The Use of Adipose-Derived Stromal Vascular Fraction Cells and Platelet Rich Plasma in Regenerative Plastic Surgery10.1002/stem.2498 ↗
17. Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre-and post-treatment evaluation10.1111/jocd.12394 ↗
18. Efficacy of subcutaneous injection of platelet-rich plasma in alopecia: A clinical and histological pilot study on a rat model with a six-month long-term follow-up experience10.1111/jocd.12425 ↗
19. The biomolecular basis of adipogenic differentiation of adipose-derived stem cells10.3390/ijms15046517 ↗
20. The Basic Mechanism of Hair Growth Stimulation by Adipose-derived Stem Cells and Their Secretory Factors10.2174/1574888X12666170829161058 ↗
21. Low-level laser (light) therapy (LLLT) for treatment of hair loss10.1002/lsm.22170 ↗
22. Low-level laser therapy for the treatment of androgenic alopecia: A review
23. Low-level laser therapy as a treatment for androgenetic alopecia10.1002/lsm.22512 ↗
24. Kintzios, S. (2002). Oregano: The Genera Origanum and Lippia (Medicinal and Aromatic Plants-Industrial Profiles), CRC Press.
25. Biological activities of antioxidants from herbs in Labiatae
26. Stimulation of rosmarinic acid in shoot cultures of oregano (Origanum vulgare) clonal line in response to proline, proline analogue, and proline precursors10.1021/jf9802629 ↗
27. Antioxidant and antiinflammatory activities of oregano extract10.1248/jhs.52.169 ↗
28. Methanolic extract of Origanum vulgare ameliorates type 1 diabetes through antioxidant, anti-inflammatory and anti-apoptotic activity10.1017/S0007114514004048 ↗
29. Phenolic compounds from Origanum vulgare and their antioxidant and antiviral activities10.1016/j.foodchem.2013.11.153 ↗
30. Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano)10.1021/np100281g ↗
31. Antioxidant and antimelanogenic properties of rosmarinic acid methyl ester from Origanum vulgare10.1016/j.foodchem.2010.04.025 ↗
32. Free radical scavenging activity of 4-(3,4-dihydroxybenzoyloxymethyl)phenyl-O-β-d-glucopyranoside from Origanum vulgare and its protection against oxidative damage10.1021/jf302329m ↗
33. Phytochemical, Pharmacological and Beneficial Effects of Green Tea
34. Green tea and the skin10.1016/j.jaad.2004.12.044 ↗
35. The specific anti-cancer activity of green tea (−)-epigallocatechin-3-gallate (EGCG)10.1007/s007260200002 ↗
36. In vivo and in vitro immunomodulatory activities of Trichilia glabra aqueous leaf extracts10.1016/S0378-8741(99)00010-0 ↗
37. Protection against 12-O-tetradecanoylphorbol-13-acetate-caused inflammation in SENCAR mouse ear skin by polyphenolic fraction isolated from green tea10.1093/carcin/14.3.361 ↗
38. Green tea and skin—Anticarcinogenic effects10.1111/1523-1747.ep12371720 ↗
39. The effects of tea polyphenolic compounds on hair loss among rodents
40. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG)10.1016/j.phymed.2006.09.009 ↗
41. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-α-reductase in the treatment of androgenetic alopecia10.1089/107555302317371433 ↗
42. Selective-Inhibition of Steroid 5 α-Reductase Isozymes by Tea Epicatechin-3-Gallate and Epigallocatechin-3-Gallate10.1006/bbrc.1995.2362 ↗
43. Outcomes of 3% green tea emulsion on skin sebum production in male volunteers10.17305/bjbms.2010.2697 ↗
44. Lycopene as the most efficient biological carotenoid singlet oxygen quencher10.1016/0003-9861(89)90467-0 ↗
45. Carotenoid–radical interactions10.1016/S0006-291X(03)00816-7 ↗
46. Antioxidant activity of carotenoids10.1016/S0098-2997(03)00030-X ↗
47. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin10.1021/jf9019745 ↗
48. Administration of capsaicin and isoflavone promotes hair growth by increasing insulin-like growth factor-I production in mice and in humans with alopecia10.1016/j.ghir.2007.04.009 ↗
49. Hair growth induction by substance P
50. In vivo and in vitro anti-inflammatory activity of Cryptostegia grandiflora Roxb. ex R. Br. leaves10.1186/0717-6287-47-32 ↗
51. Mesoporous nanocrystalline tio 2 loaded with ferulic acid for sunscreen and photo-protection: Safety and efficacy assessment10.1039/C6RA07653J ↗
52. Hair growth promoting effect of white wax and policosanol from white wax on the mouse model of testosterone-induced hair loss10.1016/j.biopha.2017.02.036 ↗
53. Parisi, O.I., Malivindi, R., Amone, F., Ruffo, M., Malanchin, R., Carlomagno, F., Piangiolino, C., Nobile, V., Pezzi, V., and Scrivano, L. (2017). Safety and Efficacy of Dextran-Rosmarinic Acid Conjugates as Innovative Polymeric Antioxidants in Skin Whitening: What Is the Evidence?. Cosmetics, 4.10.3390/cosmetics4030028 ↗
54. Flavonoids preservation and release by methacrylic acid-grafted (N-vinyl-pyrrolidone)10.3109/10837450.2012.680595 ↗